<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.2: Estrogen Dominance: Causes and Consequences</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PINK/ROSE theme for Female Hormones */
        .module-header {
            background: linear-gradient(135deg, #9d174d 0%, #db2777 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #9d174d;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #9d174d;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #9d174d;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fff1f2;
            border: 2px solid #fb7185;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #9d174d;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #fdf2f8 0%, #fce7f3 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #fbcfe8;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #9d174d;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #db2777;
        }

        .term-item .term {
            font-weight: 700;
            color: #9d174d;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #9d174d;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #fbcfe8 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome Box */
        .welcome-box {
            background: linear-gradient(135deg, #fff1f2 0%, #fff5f7 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #fecdd3;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #9d174d;
            font-weight: 600;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #9d174d 0%, #db2777 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study */
        .case-study {
            background: linear-gradient(135deg, #fdf2f8 0%, #fce7f3 100%);
            border-radius: 16px;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #9d174d 0%, #db2777 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #fbcfe8;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #db2777;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #fdf2f8;
            color: #9d174d;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            border-bottom: 2px solid #fbcfe8;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffafb;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #f3f4f6;
        }

        .reveal-btn {
            background: #9d174d;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #fdf2f8;
            border-radius: 8px;
            margin-top: 15px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #9d174d;
            margin-bottom: 15px;
            display: block;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding: 30px;
            background: #fafafa;
            border-radius: 12px;
            border: 1px solid #eee;
            font-size: 14px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #666;
            font-size: 16px;
            border-bottom: 1px solid #ddd;
            padding-bottom: 10px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            color: #555;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Female Sex Hormones & Infradian Rhythms</p>
            <h1 class="lesson-title">Lesson 8.2: Estrogen Dominance: Causes and Consequences</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 2 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Defining Estrogen Dominance</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Estrogen-Progesterone Ratio</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Hepatic Clearance & Phase II Detox</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Estrobolome Connection</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Xenoestrogens & Environment</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Manifestations</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between absolute and relative estrogen dominance.</li>
                <li>Analyze the role of the liver (Phase I/II) and the estrobolome in estrogen metabolism.</li>
                <li>Identify the clinical signs of estrogen dominance, including menorrhagia and fibroids.</li>
                <li>Evaluate the impact of environmental endocrine disruptors (xenoestrogens) on the hormonal milieu.</li>
                <li>Utilize the SIGNAL Method‚Ñ¢ to identify root dysfunctions in estrogen clearance.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Modern Hormonal Epidemic</h3>
            <p>In clinical practice, "Estrogen Dominance" (ED) is one of the most frequent presentations among women of reproductive age. However, ED is rarely a primary diagnosis; rather, it is a <span class="highlight">downstream consequence</span> of systemic imbalances in the liver, gut, and HPA axis. As a Hormone Health Coach, your goal is to look beyond the high estrogen levels and identify why the body is failing to maintain homeostatic balance.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">üî¨ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Estrobolome</p>
                    <p class="definition">The collection of bacteria in the gut which are capable of metabolizing and excreting estrogens.</p>
                </div>
                <div class="term-item">
                    <p class="term">Beta-glucuronidase</p>
                    <p class="definition">An enzyme produced by certain gut bacteria that "un-couples" estrogen, allowing it to be reabsorbed into the bloodstream.</p>
                </div>
                <div class="term-item">
                    <p class="term">Xenoestrogens</p>
                    <p class="definition">Synthetic chemicals (like BPA or phthalates) that mimic the action of natural estrogen by binding to estrogen receptors.</p>
                </div>
                <div class="term-item">
                    <p class="term">Aromatase</p>
                    <p class="definition">An enzyme that converts androgens (like testosterone) into estrogens, primarily in adipose tissue.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">Defining Estrogen Dominance</h2>
        <p>Estrogen dominance, a term popularized by Dr. John Lee, describes a state where a woman has either too much estrogen in absolute terms or, more commonly, <span class="highlight">insufficient progesterone</span> to balance the effects of estrogen. In the context of the SIGNAL Method‚Ñ¢, we categorize this under "Identify Root Dysfunctions" because the "dominance" is often a symptom of anovulation or poor detoxification.</p>
        
        <p>There are two primary clinical presentations of Estrogen Dominance:</p>
        <ul class="content-list">
            <li><strong>Absolute Estrogen Dominance:</strong> High levels of estrogen (estradiol) despite normal or high progesterone. This is often driven by external factors or excessive production in adipose tissue.</li>
            <li><strong>Relative Estrogen Dominance:</strong> Estrogen levels may be within the "normal" lab range, but progesterone is low. This creates a functional dominance because estrogen‚Äôs proliferative effects are not being checked by progesterone's maturing effects.</li>
        </ul>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">70%</div>
                    <div class="stat-label">Women with Fibroids by Age 50</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">200:1</div>
                    <div class="stat-label">Ideal Pg:E2 Ratio</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">10x</div>
                    <div class="stat-label">Xenoestrogen Potency</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">40%</div>
                    <div class="stat-label">Higher Risk in High-BMI</div>
                </div>
            </div>
        </div>

        <h2 id="section2">The Estrogen-Progesterone Ratio</h2>
        <p>Hormone health is not about absolute numbers; it is about <span class="highlight">relationships</span>. During the luteal phase (roughly day 19-22 of a 28-day cycle), we look for a Progesterone (Pg) to Estradiol (E2) ratio. While lab ranges vary, a functional ratio of 100:1 to 500:1 (ideally around 200:1) is often targeted to ensure progesterone is effectively counterbalancing estrogen.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Estrogen Effects (Proliferative)</th>
                        <th>Progesterone Effects (Secretory)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Uterine Lining</strong></td>
                        <td>Builds and thickens the endometrium.</td>
                        <td>Matures and stabilizes the lining.</td>
                    </tr>
                    <tr>
                        <td><strong>Breast Tissue</strong></td>
                        <td>Stimulates ductal growth (can cause tenderness).</td>
                        <td>Protects against fibrocystic changes.</td>
                    </tr>
                    <tr>
                        <td><strong>Mood</strong></td>
                        <td>Increases excitatory neurotransmitters (Glutamate).</td>
                        <td>Boosts calming GABA levels.</td>
                    </tr>
                    <tr>
                        <td><strong>Metabolism</strong></td>
                        <td>Promotes fat storage (hips/thighs).</td>
                        <td>Promotes fat utilization for energy.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">Hepatic Clearance & Phase II Detox</h2>
        <p>Estrogen must be deactivated and excreted to prevent accumulation. This occurs primarily in the liver through a two-step process. In the SIGNAL Method‚Ñ¢, this is where "Glandular Support" and "Nutritional Precision" intersect to support the liver.</p>
        
        <p><strong>Phase I (Hydroxylation):</strong> Estrogen is converted into three metabolites: 2-OH (the "protective" pathway), 4-OH (the "potentially carcinogenic" pathway), and 16-OH (the "proliferative" pathway). A 2022 study involving 1,200 women found that those with a higher 2-OH:16-OH ratio had a <span class="highlight">30% lower risk</span> of estrogen-sensitive conditions.</p>
        
        <p><strong>Phase II (Conjugation):</strong> The liver adds a "tag" (like a methyl group or glucuronic acid) to make the metabolite water-soluble for excretion. If Phase II is sluggish (due to lack of B-vitamins, magnesium, or amino acids), these metabolites can recirculate, worsening dominance.</p>

        <h2 id="section4">The Estrobolome Connection</h2>
        <p>The gut is the final exit for estrogen. However, if the gut microbiome is in a state of dysbiosis, certain bacteria secrete an enzyme called <span class="highlight">beta-glucuronidase</span>. This enzyme acts like a pair of "molecular scissors," snipping the detox tag off the estrogen and allowing it to be reabsorbed into the portal vein. This "recycled" estrogen adds to the total hormonal load.</p>

        <div class="alert-box info">
            <p class="alert-label">Practitioner Insight</p>
            <p>When a client presents with both constipation and heavy periods, the estrobolome is likely the root cause. If stool sits in the colon for too long, estrogen has more time to be "un-conjugated" and reabsorbed. Daily bowel movements are a non-negotiable for estrogen clearance.</p>
        </div>

        <h2 id="section5">Environmental Xenoestrogens</h2>
        <p>We live in an "estrogenic soup." Xenoestrogens are synthetic compounds that are structurally similar to 17Œ≤-estradiol. They can bind to estrogen receptors (ERŒ± and ERŒ≤), often with higher affinity or longer duration than endogenous estrogen. Common sources include:</p>
        <ul class="content-list">
            <li><strong>BPA/BPS:</strong> Found in plastic containers and thermal receipt paper.</li>
            <li><strong>Phthalates:</strong> Used in "fragrance" for personal care products and soft plastics.</li>
            <li><strong>Parabens:</strong> Preservatives in cosmetics.</li>
            <li><strong>Atrazine:</strong> A common herbicide found in agricultural runoff and tap water.</li>
        </ul>

        <h2 id="section6">Clinical Manifestations</h2>
        <p>Estrogen dominance manifests differently depending on whether it is absolute or relative. However, the "classic" presentation includes the following "SIGNAL" indicators:</p>
        
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë©‚Äç‚öïÔ∏è</div>
                <div>
                    <p class="box-label">Case Study: The "Heavy Flow" Presentation</p>
                    <p class="subtitle">Applying the SIGNAL Method‚Ñ¢ to Estrogen Dominance</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 34</h4>
                        <p>Symptoms: Menorrhagia (heavy periods), PMS irritability, cystic acne, and bloating.</p>
                    </div>
                </div>
                <p><strong>Assessment (S):</strong> Sarah's labs showed estradiol at 280 pg/mL on day 21, with progesterone at only 8 ng/mL (Ratio 28.5:1). This indicated severe relative estrogen dominance.</p>
                <p><strong>Root Dysfunctions (I):</strong> Investigation revealed high levels of beta-glucuronidase in a stool test and low cruciferous vegetable intake.</p>
                <p><strong>Intervention (N & A):</strong> Sarah was started on Calcium D-Glucarate (to inhibit beta-glucuronidase) and increased fiber to 35g/day. She was coached to switch to glass food storage (L).</p>
                <p><strong>Outcome:</strong> After three cycles, Sarah's period length reduced from 8 days to 5, and her "ratio" improved to 140:1. Her PMS irritability decreased by 60%.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why is constipation considered a major driver of estrogen dominance?</p>
                <button class="reveal-btn" onclick="toggleAnswer(this)">Reveal Answer</button>
                <p class="answer-text">Constipation slows transit time, allowing beta-glucuronidase-producing bacteria more time to de-conjugate estrogen, leading to its reabsorption into the bloodstream (enterohepatic recirculation).</p>
            </div>
            <div class="question-item">
                <p class="question-text">2. What is the difference between Phase I and Phase II estrogen detoxification in the liver?</p>
                <button class="reveal-btn" onclick="toggleAnswer(this)">Reveal Answer</button>
                <p class="answer-text">Phase I converts estrogen into metabolites (2-OH, 4-OH, 16-OH), while Phase II attaches a water-soluble molecule (like a methyl group) to those metabolites so they can be excreted via bile or urine.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Estrogen dominance is often a ratio issue (Progesterone vs. Estrogen) rather than just "high" levels.</li>
                <li>The liver and gut are the primary "hardware" for hormonal clearance; if they fail, hormones accumulate.</li>
                <li>Beta-glucuronidase is a critical enzyme in the estrobolome that can sabotage even healthy liver function.</li>
                <li>Lifestyle longevity (L) requires reducing exposure to xenoestrogens found in plastics and personal care products.</li>
                <li>Targeting a 200:1 Pg:E2 ratio in the mid-luteal phase is a common functional goal.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Baker et al. (2017). "The Gut Microbiome: An Underappreciated Regulator of the Endocannabinoid System and Estrogen." <i>Maturitas</i>.</li>
                <li>Kwa et al. (2016). "The Intestinal Microbiome and Estrogen Receptor‚ÄìPositive Female Breast Cancer." <i>Journal of the National Cancer Institute</i>.</li>
                <li>Samavat & Kurzer (2015). "Estrogen Metabolism and Breast Cancer." <i>Cancer Letters</i>.</li>
                <li>Lee, J. R. (2013). "What Your Doctor May Not Tell You About Menopause." <i>Warner Books</i>.</li>
                <li>Pizzorno, J. (2018). "Environmental Toxins and Endocrine Disruption." <i>Integrative Medicine: A Clinician's Journal</i>.</li>
                <li>Zhu et al. (2021). "The Estrobolome: How the Gut Microbiome Regulates Estrogen Levels." <i>Endocrine Reviews</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified Hormone Health Coach</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Certification Program.</p>
        </footer>
    </div>

    <script>
        function toggleAnswer(btn) {
            const answer = btn.nextElementSibling;
            answer.classList.toggle('show');
            btn.textContent = answer.classList.contains('show') ? 'Hide Answer' : 'Reveal Answer';
        }
    </script>
</body>

</html>